1N9.F · NeutriSci International Inc

-

Please sign in to comment on 1N9.F

1 Comment

Admin

3 years, 7 months ago

NeutriSci International Inc is currently in a long term uptrend where the price is trading 1.5% above its 200 day moving average.

From a valuation standpoint, the stock is 74.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 332.6.

NeutriSci International Inc's total revenue rose by 68.8% to $60K since the same quarter in the previous year.

Its net income has dropped by 119.6% to $-633K since the same quarter in the previous year.

Finally, its free cash flow grew by 53.4% to $-274K since the same quarter in the previous year.

Based on the above factors, NeutriSci International Inc gets an overall score of 4/5.

Sector	Healthcare
Industry	Drug Manufacturers-Specialty & Generic
ISIN	CA64129Y1079
CurrencyCode	EUR
Exchange	F

Beta	1.05
Target Price	None
PE Ratio	None
Market Cap	3M
Dividend Yield	0.0%

ABOUT

NeutriSci International Inc

NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada, the United States, Europe, Asia, and South America. It offers neuenergy, an energy tablet designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with LaSanta Botanicals, Nutritional High, and Naturally Splendid. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

1N9.F · NeutriSci International Inc

-

NeutriSci International Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest NeutriSci International Inc using a moving average strategy